JPRN-UMIN000007244已完成2 期
A randomized phase II study of Gemcitabine or Gemcitabine + S-1 as adjuvant chemotherapy for resected biliary tract cancer - A randomized phase II study of Gemcitabine or Gemcitabine + S-1 as adjuvant chemotherapy for resected biliary tract cancer
Adjuvant Therapy for BTC Research Group0 个研究点目标入组 130 人开始时间: 2012年2月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) active interstitial pneumonia (2) unstable pleural effusion (3) with metastasis (4) patients with uncured other malignancies (5) active severe infection (6) patients with severe complication (7) patients with uncontrollable angina pectoris or a new onset of myocardial infarction within 3 months (8) uncontrollable diabetes mellitus, hypertension (9) psychiatric disorder (10) women in pregnancy, potential pregnancy, or breast feeding (11) other inappropriate cases according to primary doctor's evaluation
研究者
相似试验
进行中（未招募）
1 期
Full-dose single-agent chemotherapy (gemcitabine) or reduced-dose combination chemotherapy as first palliative treatment for fragile patients with advanced pancreatic cancer.Pancreatic CancerEUCTR2021-005067-52-DKAalborg University Hospital, Department of Oncology100
已完成
2 期
Randomized phase II study comparing Gemcitabine versus TS-1 for advanced bile duct cancerAdvanced bile duct cancerJPRN-UMIN000001595Osaka International Cancer Institute Department of Hepatobiliary and pancreatic Oncology110
未知
2 期
Randomized phase II trial of gemcitabine(GEM) and carboplatin (CBDCA) with or without Dexamethasone(Dex) in untreated non-small cell lung cancer (NSCLC).on small cell lung cancerJPRN-UMIN000000547Kyoto Thoracic Oncology Research Group (KTORG)76
已完成
2 期
Randomized phase II study comparing Gemcitabine chemoradiotherapy with Gemcitabine chemotherapy for unresectable locally advanced pancreatic cancer.nresectable locally advanced pancreatic cancer.JPRN-UMIN000012253Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Medical Oncology110
进行中（未招募）
2 期
GABARNANCE TrialJPRN-jRCTs031180319Ikeda Masafumi110